Hepion Pharmaceuticals Inc [NASDAQ: HEPA] surged by $0.0 during the normal trading session on while it closed the day at $0.17.
Hepion Pharmaceuticals Inc stock has also gained 5.43% of its value over the past 7 days. However, HEPA stock has declined by -73.32% in the 3 months of the year. Over the past six months meanwhile, it has lost -71.50% and lost -63.62% year-on date.
The market cap for HEPA stock reached $1.81 million, with 10.62 million shares outstanding and 10.61 million shares in the current float. Compared to the average trading volume of 17.25M shares, HEPA reached a trading volume of 16931270 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hepion Pharmaceuticals Inc [HEPA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HEPA shares is $22.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HEPA stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Hepion Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 20, 2020.
HEPA stock trade performance evaluation
Hepion Pharmaceuticals Inc [HEPA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.43. With this latest performance, HEPA shares dropped by -69.48% in over the last four-week period, additionally sinking by -71.50% over the last 6 months – not to mention a drop of -89.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HEPA stock in for the last two-week period is set at 33.71, with the RSI for the last a single of trading hit 33.83, and the three-weeks RSI is set at 34.56 for Hepion Pharmaceuticals Inc [HEPA]. The present Moving Average for the last 50 days of trading for this stock 0.4433, while it was recorded at 0.1675 for the last single week of trading, and 0.7732 for the last 200 days.
Hepion Pharmaceuticals Inc [HEPA]: An insightful look at the core fundamentals
Hepion Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Hepion Pharmaceuticals Inc [HEPA]: Institutional Ownership
There are presently around $7.85%, or 7.85%% of HEPA stock, in the hands of institutional investors.
